BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1291200)

  • 1. Vitamin D and calcium metabolism in children with nephrotic syndrome of normal renal function.
    Huang JP; Bai KM; Wang BL
    Chin Med J (Engl); 1992 Oct; 105(10):828-32. PubMed ID: 1291200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium and vitamin D metabolism in children with nephrotic syndrome.
    Freundlich M; Bourgoignie JJ; Zilleruelo G; Abitbol C; Canterbury JM; Strauss J
    J Pediatr; 1986 Mar; 108(3):383-7. PubMed ID: 3485195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium and vitamin D homeostasis in patients with heavy proteinuria.
    Saha H
    Clin Nephrol; 1994 May; 41(5):290-6. PubMed ID: 8050209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium and vitamin-D metabolism in nephrotic syndrome.
    Alon U; Chan JC
    Int J Pediatr Nephrol; 1983 Jun; 4(2):115-8. PubMed ID: 6688609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanism of impaired calcium and vitamin D metabolism in nephrotic rats.
    Mizokuchi M; Kubota M; Tomino Y; Koide H
    Kidney Int; 1992 Aug; 42(2):335-40. PubMed ID: 1328752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D physiology.
    Lips P
    Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting calcium metabolism in disorders of the kidney.
    Favus MJ
    Ann Clin Lab Sci; 1981; 11(4):327-32. PubMed ID: 7023346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
    Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome.
    Auwerx J; De Keyser L; Bouillon R; De Moor P
    Nephron; 1986; 42(3):231-5. PubMed ID: 3753749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
    Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
    Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum.
    Peacock M
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N87-94. PubMed ID: 12412783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
    Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
    J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitamin disturbances in chronic renal insufficiency. II. Fat soluble vitamins].
    Pietrzak I
    Przegl Lek; 1996; 53(1):29-32. PubMed ID: 8711172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal vitamin D metabolism, intestinal calcium transport, and bone calcium status in the spontaneously hypertensive rat compared with its genetic control.
    Lucas PA; Brown RC; Drüeke T; Lacour B; Metz JA; McCarron DA
    J Clin Invest; 1986 Jul; 78(1):221-7. PubMed ID: 3755141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
    Loras B; Parchoux B; Durr F
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.